Dr. Anderson on Addressing Unmet Needs in Myeloma With Descartes-11
March 25th 2021
Kenneth C. Anderson, MD, discusses potentially addressing unmet needs in patients with multiple myeloma through the use of the mRNA-based CAR T-cell therapy Descartes-11.